MASTER INVESTOR SHOW 2025
The UK's largest event for private investors
Business Design Centre, London, 29 March 2025
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Ananda Pharma plc
Ananda Pharma (AQSE: ANA) is a UK-based biopharmaceutical company developing regulatory approved, cannabinoid medicines to treat complex, chronic conditions, including epilepsy (trials funded by NHS England and NIHR), endometriosis (funded by NHS Scotland) and chemotherapy pain (funded by NIHR). The Company is led by successful entrepreneurs and is working with a team of world-class scientists, including globally respected Key Opinion Leaders at the University of Edinburgh, Great Ormond Street Hospital for Children and University College London.
Ticker: AQSE:ANA
https://investors.anandadevelopments.com/s/256ae7
Investor Hub: https://investors.anandapharma.co.uk/s/54ee8b
Get your ticket
Don't miss out on the UK's largest event for private investors - secure your ticket today.
SUBSCRIBE
FOLLOW US